Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 May 1;179(5):500-507.
doi: 10.1001/jamapediatrics.2025.0010.

Tailored Adherence Incentives for Childhood Asthma Medications: A Randomized Clinical Trial

Chén C Kenyon  1   2   3 , William O Quarshie  4 , Rui Xiao  3 , Mishaal Yazdani  1 , Carina M Flaherty  5 , G Chandler Floyd  3 , Victoria A Miller  3   6 , Tyra C Bryant-Stephens  1   2   3 , Joseph J Zorc  3   7 , Chris Feudtner  2   3
Affiliations
Randomized Controlled Trial

Tailored Adherence Incentives for Childhood Asthma Medications: A Randomized Clinical Trial

Chén C Kenyon et al. JAMA Pediatr. .

Abstract

Importance: Differential adherence to efficacious preventive medications is one potentially modifiable driver of racial disparities in childhood asthma outcomes.

Objective: To determine the effect of a financial incentive-enhanced intervention on adherence to inhaled asthma preventive medication in a high-risk, predominantly racially minoritized cohort of children with asthma.

Design, setting, and participants: This was a randomized clinical trial conducted from September 2019 through June 2022 at a large mid-Atlantic pediatric health system in the US. Children were eligible if they were between 5 and 12 years old, prescribed a preventive inhaler for daily use, and had at least 2 asthma exacerbations requiring systemic steroids in the preceding year. Data were analyzed from December 2022 to December 2024.

Intervention: Inhaled medication use was monitored using electronic inhaler sensors over a 7-month period. Families who completed a 1-month run-in interval were randomized to 1 of 3 arms for a 3-month experiment interval: (1) daily text message medication reminders, weekly adherence feedback, and gain-framed, financial incentives of up to $1 per day (full intervention); (2) daily text message medication reminders and weekly adherence feedback (hybrid intervention); or (3) no reminders, feedback, or incentives (active control). Medication adherence monitoring then continued for a 3-month observation interval, where all arms reverted to active control conditions.

Main outcomes and measures: The primary outcome was adherence to inhaled maintenance medication during the experiment; secondary outcomes included adherence during the observation phase. The study was powered to detect a difference in average monthly adherence between the full intervention and active control condition.

Results: Of the 106 children randomized, 99 had at least 1 month of monitoring data (56 male [57%] and 43 female [43%]; mean [SD] age, 8.0 [2.3] years). Most participants (81 [82%]) identified as non-Hispanic Black and demographic and clinical characteristics were similar across study arms. During the experiment interval, participants receiving the full intervention had a 15-percentage point (95% CI, 2-29 percentage points) higher inhaled maintenance medication adherence compared with participants in the active control. There was no evidence of adherence differences in the observation interval.

Conclusion and relevance: While a financial incentive-enhanced mobile health intervention led to higher inhaled preventive medication adherence as compared with the active control group, there was no evidence for enduring effect after the intervention components ceased, consistent with other studies that include financial incentives to encourage behavior change.

Trial registration: ClinicalTrials.gov Identifier: NCT03907410.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Kenyon reported grants from the National Institutes of Health/National Heart, Lung, and Blood Institute (K23HL136842) during the conduct of the study. Dr Zorc reported grants from the National Institutes of Health/National Heart, Lung, and Blood Institute during the conduct of the study. No other disclosures were reported.

Comment on

References

    1. Akinbami LJ, Moorman JE, Simon AE, Schoendorf KC. Trends in racial disparities for asthma outcomes among children 0 to 17 years, 2001-2010. J Allergy Clin Immunol. 2014;134(3):547-553.e5. doi: 10.1016/j.jaci.2014.05.037 - DOI - PMC - PubMed
    1. US Centers for Disease Control and Prevention . Most recent national asthma data. Accessed February 11, 2025. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm
    1. Canino G, McQuaid EL, Rand CS. Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol. 2009;123(6):1209-1217. doi: 10.1016/j.jaci.2009.02.043 - DOI - PMC - PubMed
    1. Drotar D, Bonner MS. Influences on adherence to pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr. 2009;30(6):574-582. doi: 10.1097/DBP.0b013e3181c3c3bb - DOI - PubMed
    1. National Asthma Education and Prevention Program . Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(5)(suppl):S94-S138. doi: 10.1016/j.jaci.2007.09.029 - DOI - PubMed

Substances

Associated data